Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001790340-25-000094
Filing Date
2025-07-03
Accepted
2025-07-03 09:12:08
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751548321.html 4  
1 FORM 4 wk-form4_1751548321.xml 4 6206
  Complete submission text file 0001790340-25-000094.txt   7657
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNEERING CORPORATION 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address
Zeskind Benjamin J. (Reporting) CIK: 0001870062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40675 | Film No.: 251103904